13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)

Page 9 of 9

Page 9 of 9 SEC Filing

Exhibit A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of common stock, $0.001 par value per share, of Eagle Pharmaceuticals, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as Exhibit A to such Schedule 13G.  In evidence thereof, the undersigned hereby execute this agreement this Twenty-First day of January, 2016.
 
/s/  Peter S. Park
 
 
Peter S. Park
 
       
       
       
 
PARK WEST ASSET MANAGEMENT LLC
 
       
 
By:
/s/    Grace Jimenez
 
   
Name: Grace Jimenez
 
   
Title: Chief Financial Officer
  

9


Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

Page 9 of 9